Amgen (AMGN) Dividends Paid - Common (2011 - 2026)
Amgen (AMGN) recorded quarterly Dividends Paid - Common of $1.4 billion in Q1 2026, up 5.85% quarter-over-quarter from $1.3 billion in Q4 2025, and up 6.18% on a YoY basis from $1.3 billion in Q1 2025.
Amgen (AMGN) Dividends Paid - Common (2011 - 2026) Analysis & Trends
Amgen's Dividends Paid - Common history runs 16 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Dividends Paid - Common rose 6.18% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $5.2 billion (up 6.12% YoY), while the FY2025 annual figure was $5.1 billion, up 6.04% from the prior year.
- Dividends Paid - Common was $1.4 billion for Q1 2026 at Amgen, up from $1.3 billion in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $1.4 billion in Q1 2026 to a low of $1.0 billion in Q2 2022.
- Historically, Dividends Paid - Common has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
- The sharpest annual moves came in 2022 and 2023: Dividends Paid - Common gained 2.98% in 2022, then gained 9.83% in 2023.
- A 5-year view of Dividends Paid - Common shows it stood at $1.0 billion in 2022, then grew by 9.62% to $1.1 billion in 2023, then increased by 5.7% to $1.2 billion in 2024, then gained by 6.47% to $1.3 billion in 2025, then increased by 5.85% to $1.4 billion in 2026.
- The last three Dividends Paid - Common figures came in at $1.4 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -866.88 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 1.55 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 3.13 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 3.09 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 1.28 Bn |
| 10 | Novartis Ag | 109.78 Bn | 109.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.36 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Dec 31, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Dec 31, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.14 Bn |
| Dec 31, 2023 | 1.14 Bn |